DI GIORGIO, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 388
EU - Europa 236
AS - Asia 118
AF - Africa 3
Totale 745
Nazione #
US - Stati Uniti d'America 386
IE - Irlanda 98
IT - Italia 86
HK - Hong Kong 84
VN - Vietnam 21
CN - Cina 10
BE - Belgio 9
DE - Germania 9
FI - Finlandia 7
RU - Federazione Russa 7
UA - Ucraina 6
NL - Olanda 4
SE - Svezia 3
AT - Austria 2
CA - Canada 2
CI - Costa d'Avorio 2
FR - Francia 2
CH - Svizzera 1
EE - Estonia 1
GB - Regno Unito 1
IR - Iran 1
KR - Corea 1
LB - Libano 1
MA - Marocco 1
Totale 745
Città #
Chandler 133
Dublin 94
Hong Kong 84
Perugia 40
San Mateo 22
Dong Ket 21
Ann Arbor 20
Medford 16
Princeton 16
Altamura 15
Lawrence 13
Wilmington 11
Brussels 9
Los Angeles 8
Ashburn 7
Des Moines 6
Redwood City 6
Beijing 5
Andover 4
Den Haag 4
Florence 4
Lappeenranta 4
Saint Petersburg 4
Helsinki 3
Houston 3
Redmond 3
Abidjan 2
Bologna 2
Cambridge 2
Menlo Park 2
Naples 2
San Diego 2
Toronto 2
Vienna 2
Boardman 1
Boydton 1
Cava Dei Tirreni 1
Cormeilles-en-Parisis 1
Esslingen am Neckar 1
Frankfurt am Main 1
Fremont 1
Harbin 1
Jacksonville 1
Jinan 1
Lugano 1
Nocera Umbra 1
Norwalk 1
Philadelphia 1
Rabat 1
Radeberg 1
San Paolo di Civitate 1
Seattle 1
Seoul 1
Tallinn 1
Tenhult 1
Woodbridge 1
Zanjan 1
Totale 594
Nome #
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of Light 72
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 69
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 54
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 42
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 40
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 37
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 36
Bile Acids Activated Receptors in Inflammatory Bowel Disease 34
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 32
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 32
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 32
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 30
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 28
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 28
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 26
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 24
Obeticholic Acid: An Update of Its Pharmacological Activities in Liver Disorders 24
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 23
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 22
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 21
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 19
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 17
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 14
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 13
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 8
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 6
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 5
Totale 788
Categoria #
all - tutte 3.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202028 0 1 0 0 2 0 2 0 6 9 5 3
2020/202174 5 1 2 1 21 6 1 3 2 6 4 22
2021/2022125 2 20 0 3 1 1 11 21 3 15 16 32
2022/2023409 27 61 3 35 38 46 0 22 151 2 14 10
2023/2024151 10 15 4 6 12 1 47 28 19 9 0 0
Totale 788